American Journal of Ophthalmology
Volume 137, Issue 1 , Pages 77-83 , January 2004

Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial

  • THE OPTIC NEURITIS STUDY GROUP

      Affiliations

    • Corresponding Author InformationInquiries to Robin L. Gal, MSPH, Optic Neuritis Study Group Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Dr, Suite 350, Tampa, FL 33647, USA; fax: (813) 975-8761
    • The writing committee, investigators, and coordinators who participated in the study are listed in the Appendix.
    • Corresponding Author InformationInquiries to Robin L. Gal, MSPH, Optic Neuritis Study Group Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Dr, Suite 350, Tampa, FL 33647, USA; fax: (813) 975-8761
    • ontt@jaeb.org

,Accepted 15 July 2003.

References 

  1. Optic Neuritis Study Group. High and low risk profiles for the development of multiple sclerosis within ten years after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 2003;121:944–949
  2. Beck RW, Cleary PA, Anderson MM, et al.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992;326:581–588
  3. Beck RW, Cleary PA, Trobe JD, et al.  The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 1993;329:1764–1769
  4. Cleary PA, Beck RW, Anderson MM, et al.  Design, methods, and conduct of the Optic Neuritis Treatment Trial. Control Clin Trials. 1993;14:123–142
  5. Optic Neuritis Study Group . The clinical profile of acute optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109:1673–1678
  6. Optic Neuritis Study Group . Visual function five years after optic neuritis (experience of the Optic Neuritis Treatment Trial). Arch Ophthalmol. 1997;115:1545–1552
  7. Poser CM, Paty DW, Scheinberg L, et al.  New diagnostic criteria for multiple sclerosis (guidelines for research protocols). Ann Neurol. 1983;13:227–231
  8. Mangione CM, Lee PP, Gutierrez P, et al.  Development of the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25). Arch Ophthal. 2001;119:1050–1058
  9. Bradley WG, Whitty CWM. Acute optic neuritis (prognosis for development of multiple sclerosis). J Neurol Neurosurg Psychiatry. 1968;31:10–18
  10. Cohen M, Lessell S, Wolf P. A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis. Neurology. 1979;29:208–213
  11. Hutchinson WM. Acute optic neuritis and the prognosis for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1976;39:283–289
  12. Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT. Optic neuritis (a population-based study in Olmsted County, Minnesota). Neurology. 1995;45:244–250
  13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis (An expanded disability status scale (EDSS)). Neurology. 1983;33:1444–1452

☆ This study was supported by a Cooperative Agreement (U10 EY09435) from the National Eye Institute, National Institutes of Health.

PII: S0002-9394(03)00862-6

doi: 10.1016/S0002-9394(03)00862-6

American Journal of Ophthalmology
Volume 137, Issue 1 , Pages 77-83 , January 2004

Article Tools

* Image Usage & Resolution